中国医药科学Issue(5)：115-117,3.
血清CA125变化对判断卵巢癌疗效的价值探讨
Discussion on the value of changes of serum CA125 in the prediction of curative effects of ovarian cancer
黄雪娉 1徐稳深2
作者信息
- 1. 广东省博罗县人民医院检验科，广东博罗516100
- 2. 广东省博罗县人民医院肿瘤科，广东博罗516100
- 折叠
摘要
Abstract
Objective To explore the changes of serum CA125 in the prediction of curative effects of ovarian cancer. Methods 78 patients with ovarian cancer who were admitted to our hospital from June 2012 to June 2013 were selected as subjects, and randomly assigned to treatment group and control group based on admission order, with 39 patients in each group. The treatment group received IPCH, while the control group received perfusion chemotherapy during operations. Clinical curative effects and changes of serum CA125 before and after treatment were compared between the two groups. Results Total effective rate in the treatment group was significantly higher than that in the control group and the difference was statistically significant(P<0.05). The changes of serum CA125 after the chemotherapy in the treatment group were significantly better than those in the control group, and the differences were statistically significant(P<0.05). Conclusion Monitoring the changes of serum CA125 for patients with ovarian cancer is of guiding significance for the evaluation of clinical effects of chemotherapy methods and relevant medication.关键词
血清CA125/卵巢癌/腹腔热灌注化疗/静脉化疗Key words
Serum CA125/Ovarian cancer/IPCH/Intravenous chemotherapy分类
医药卫生引用本文复制引用
黄雪娉,徐稳深..血清CA125变化对判断卵巢癌疗效的价值探讨[J].中国医药科学,2014,(5):115-117,3.
